Novel approaches to immunoprophylaxis for toxocariasis

Toxocara: The Enigmatic Parasite

Volumn , Issue , 2006, Pages 174-194

  Hrĉková, Gabriela ^a  

^a PARASITOLOGICAL INSTITUTE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35348903957     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (106)

1. Abo-Shehada, M.N. and Herbert, I.V. (1984) The migration of larval Toxocara canis in mice. II. Postintestinal migration in primary infection. Veterinary Parasitology 17, 75-83.
2. Abo-Shehada, M.N., Al-Zubaidy, B.A. and Herbert, I.V. (1991) Acquired immunity to Toxocara canis infection in mice. Veterinary Parasitology 38, 289-298.
3. Akao, N. (1985) Immune response to excretory-secretory products of second stage larvae of Toxocara canis: humoral immune response relating to larval trapping in the livers of reinfected mice. Japanese Journal of Parasitology 34, 293-300.
4. Akao, N., Kondo, K., Okamoto, T. and Yoshimura, H. (1983) Antigenic analysis of excretory-secretory products of second larvae of Toxocara canis and the antigen recognition in the course of infection. Japanese Journal of Parasitology 32, 541-548.
5. Amerasinghe, P.H., Rajapakse, R.P., Llyod, S. and Fernando, S.T. (1992) Antigen-induced protection against infection with Toxocara vitulorum larvae in mice. Parasitology Research 78, 643-647.
6. Aucouturier, J., Dupuis, L. and Ganne, V. (2001) Adjuvants designed for veterinary and human vaccines. Vaccine 19, 2666-2672.
7. Badley, J.E., Grieve, R.B., Rockey, J.H. and Glickman, L.T. (1987a) Immune-mediated adherence of eosinophils to Toxocara canis infective larvae: the role of excretory-secretory antigens. Parasite Immunology 9, 133-143.
8. Badley, J.E., Grieve, R.B., Bowman, D.D., Glickman, L.T. and Rockey, J.H. (1987b) Analysis of Toxocara canis larval excretory-secretory antigens: physiochemical characterisation and antibody recognition. Journal of Parasitology 73, 593-600.
9. Bangham, A.D. (1968) Membrane models with phospholipids. Progress in Biophysics and Molecular Biology 18, 29-95.
10. Bardon, R., Cuellar, C., Del Aguila, C. and Guillen, J.L. (1995) Evaluation of mebendazole activity on experimental murine toxocariasis by immune complexes determination. Journal of Veterinary Medicine B42, 235-246.
11. Barriga, O.O. (1988) A critical look at the importance, prevalence and control of toxocariasis and the possibilities of immunological control. Veterinary Parasitology 29, 195-234.
12. Barriga, O.O. and Carrillo, M. (1987) Immunization and protection associated antigens in Toxocara canis infections of laboratory animals. In: 62nd Annual Meeting of American Society of Parasitologists, Lincoln, Nebraska, 2-6 August (abstract 86).
13. Barriga, O.O. and Myser,W.C. (1987) Effects of irradiation on the biology of the infective larvae of Toxocara canis in the mouse. Journal of Parasitology 73, 89-94.
14. Barriga, O.O. and Omar, H.M. (1992) Immunity to Toxocara vitulorum repeated infections in a rabbit model. Veterinary Immunology and Immunopathology 33, 249-260.
15. Bass, J.L., Mehta, K.A., Glickman, L.T. and Eppes, B.M. (1983) Clinically inapparent Toxocara infection in children. New England Journal of Medicine 308, 723-724.
16. Bogan, J.A. and Marriner, S. (1980) Analysis of benzimidazoles in body fluids by high-performance liquid chromatography. Journal of Pharmaceutical Sciences 69, 422-423.
17. Bohn, J.A. and BeMiller, J.N. (1995) (1-3)-b-d-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydrate Polymers 28, 3-14.
18. Bowles, V.M., Brandon, M.R. and Meeusen, E. (1995) Characterisation of local antibody responses to the gastrointestinal nematode Haemonchus contortus. Immunology 84, 669-674.
19. Bowman, D.D., Mika-Grieve, M. and Grieve, R.B. (1987) Circulating excretory-secretory antigen levels and specific antibody responses in mice infected with Toxocara canis. American Journal of Tropical Medicine and Hygiene 36, 75-82.
20. Cameron, S.B., Stolte, E.H., Chow, A.W. and Savelkoul, H.F. (2003) T helper cell polarisation as a measure of the maturation of the immune response. Mediators of Inflammation 12, 285-92.
21. Concepcion, J.E. and Barriga, O.O. (1985) Transfer of infection-induced immune protection to Toxocara canis in a mouse model. Veterinary Immunology and Immunopatholology 9, 371-382.
22. Cuellar, C., Fenoy, S., Del Aguila, C. and Guillen, J.L. (2001) Isotype responses in murine experimental toxocariasis. Memorias de Instituto Oswaldo Cruz 96, 549-553.
23. Danyes, R.A., Araneo, B.A., Dowell, T.A., Huang, K. and Dudley, D. (1990) Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. Journal of Experimental Medicine 171, 979-996.
24. Delgado, O., Botto, C., Mattei, R. and Escalante, A. (1989) Effect of albendazole in experimental toxocariasis of mice. Annals of Tropical Medicine and Parasitology 83, 621-624.
25. Del Prete, G.F., De Carli, M. and Mastromauro, C. (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. Journal of Clinical Investigation 88, 346-350.
26. Dent, L.A., Daly, C.M., Mayrhofer, G., Zimmerman, T., Hallett, A., Bignold, L.P., Creaney, J. and Parson, J.C. (1999) Interleukin-5 transgenic mice show enhanced resistance to primary infection with Nippostrongylus brasiliensis but not primary infection with Toxocara canis. Infection and Immunity 67, 989-993.
27. Dessein, A.J., Parker, W.L., James, S.L. and David, J.R. (1981) IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophilic response to Trichinella spiralis infection. Journal of Experimental Medicine 153, 423-436.
28. De Savigny, D.H. (1975) In vitro maintenance of Toxocara canis larvae and simple method for production of Toxocara ES antigens for use in serodiagnosis tests for visceral larva migrans. Journal of Parasitology 61, 781-782.
29. Dvorožnáová, E., Borošková, Z., Dubinsky P., Tomašovicová, O., Hralová, V. and Machnická, B. (1999) Immunomodulative effects of muramyldipeptide in mice with larval toxocarosis. Parasitology Research 85, 1034-1040.
30. Dvorožnáová, E., Borošková, Z., Dubinsky P., Tomašovicová, O. and Machnická, B. (2000) Toxocara canis in mice: immune responses after infection and immunization. Helminthologia 37, 199-204.
31. Dvorožnáová, E., Borošková, Z. and Tomašovicová, O. (2002) Immune responses in mice immunized with Toxocara canis antigens. Helminthologia 39, 59-66.
32. Fan, C.K., Lin, Y.H., Du, W.Y. and Su, K.E. (2003) Infectivity and pathogenicity of 14-month-cultured embryonated eggs of Toxocara canis in mice. Veterinary Parasitology 113, 145-155.
33. Fattah, D.I., Maizels, R.M., McLaren, D.J. and Spry, C.J.F. (1986) Toxocara canis: interaction of human blood eosinophils with the infective larvae. Experimental Parasitology 61, 421-431.
34. Fielding, R.M. (1991) Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. Clinical Pharmaceutics 21, 155-164.
35. Geldhof, P., Vercauteren, I., Vercruysse, J., Knox, D.P., van Den Broeck, W. and Claerebout, E. (2004) Validation of the protective Ostertagia ostertagi ES-thiol antigens with different adjuvantia. Parasite Immunology 26, 37-43.
36. Glickman, L.T. and Schantz, P.M. (1981) Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiological Reviews 3, 230-250.
37. Glickman, L.T., Dubey, J.P. and Winslow, L.J. (1981) Serological response of ascarid-free dogs to Toxocara canis infection. Parasitology 82, 383-387.
38. Gottschall, D.W., Theodorides, V.J. and Wang, R. (1990) The metabolism of benzimidazole anthelmintics. Parasitology Today 6, 115-124.
39. Grieve, R.B., Stewart,V.A. and Parsons, J.C. (1993) Immunobiology of larval toxocariasis (Toxocara canis): a summary of recent research. In: Lewis, J.W. and Maizels, R.M. (eds) Toxocara and Toxocariasis: Clinical, Epidemiological and Molecular Perspectives. Institute of Biology, London, pp. 117-124.
40. Hirano, K. and Hunt, A.C. (1985) Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration. Journal of Pharmaceutical Sciences 74, 915-921.
41. Hotez, P.J., Ashcom, J., Zhan, B., Bethony, J., Loukas, A., Hawdon, J., Wang, Y., Jin, Q., Jones, K.C., Dobardzic, A., Dobardzic, R., Bolden, J., Essiet, I., Brandt, W., Russell, P.K., Zook, B.C., Howard, B. and Chacon, M. (2003) Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae. Journal of Parasitology 89, 853-865.
42. Hrcková G. and Velebny S. (2001) Treatment of Toxocara canis infections in mice with liposome-incorporated benzimidazole carbamates and immunomodulator glucan. Journal of Helminthology 75, 141-146.
43. Hrcková, G., Velebny S., Tomašovicová, O., Medvedová, M. and Pajersky A. (2000) Pathomorphological changes in mice infected with Toxocara cati following administration of fenbendazole and glucan. Acta Parasitologica 46, 313-320.
44. Inuo, G., Akao, N., Kohsaka, H., Saito, I., Miyasaka, N. and Fujita, K. (1995) Toxocara canis adult worm antigen induces proliferative response of healthy human peripheral blood mononuclear cells. Parasite Immunology 17, 77-84.
45. Jacobs, D.E. and Fisher, M.A. (1993) Recent developments in the chemotherapy of Toxocara canis infection in puppies and the prevention of toxocariasis. In: Lewis, J.W. and Maizels, R.M. (eds) Toxocara and Toxocariasis, Clinical, Epidemiological, and Molecular Perspectives. Institute of Biology, London, pp. 111-116.
46. Janeway, C.C. and Travers, P. (1994) T-cell mediated immunity. In: Janeway, C.A., Travers, P. (eds) Immunobiology. The Immune System in Health and Disease. Current Biology Ltd, Middlesex House, London, pp. 120-154.
47. Jarrett, E.E., Haig, D.M. and Bazin, H. (1976) Time course studies on rat IgE production in Nippostrongylus brasiliensis infection. Clinical Experimental Immunology 24, 346-351.
48. Joseph, M. (1982) Effector functions of phagocytic cells against helminths. Clinics in Immunology and Allergy 2, 567-595.
49. Jungersen, G., Eriksen, L., Nansen, P., Lind, P., Rasmussen, T. and Meeusen, E.N. (2001) Regional immune responses with stage-specific antigen recognition profiles develop in lymph nodes of pigs following Ascaris suum larval migration. Parasite Immunology 23, 185-194.
50. Kamiya, M., Ooi, H.K. and Nomura, T. (1987) The effect of irradiation on the viability and migratory ability of second-stage larvae of Toxocara canis in mice. Veterinary Parasitology 24, 87-92.
51. Kayes, S.G. (1997) Human toxocariasis and the visceral larva migrans syndrome: correlative immunopathology. In: Freedman, D.O. (ed) Immunopathogenetic Aspects of Disease Induced by Helminth Parasites. Karger, Basel, pp. 99-124.
52. Kayes, S.G. and Oaks, J.A. (1980) Toxocara canis: T lymphocyte function in murine visceral larva migrans and eosinophilia onset. Experimental Parasitology 49, 47-55.
53. Kennedy, M.W., Quereshi, E.M. and Fraser, M.R. (1989) Antigenic relationship between the surfaceexposed, secreted and somatic materials of the nematode parasites Ascaris lumbricoides, Ascaris suum and Toxocara canis. Clinical and Experimental Immunology 75, 493-500.
54. Knox, D.P., Redmond, D.L., Newlands, G.F., Skuce, P.J., Pettit, D. and Smith, D.W. (2003) The nature and prospects for gut membrane proteins as vaccine candidates for Haemonchus contortus and other ruminant trichostrongyloids. International Journal for Parasitology 33, 1129-1137.
55. Kogan, G. (2000) (1-3, 1-6)-b-d-Glucans of yeasts and fungi and their biological activity. In: Atta-ur-Rahman (ed.) Studies in Natural Products Chemistry 23, 107-152.
56. Kondo, K., Shimada, Y., Kurimoto, H. and Oda, K. (1976) Experimental studies on visceral larva migrans. Japanese Journal of Parasitology 25, 371-376.
57. Lacey, E. (1990) Mode of action of benzimidazoles. Parasitology Today 6, 112-115.
58. Lee, H.F. (1960) Effect of superinfection on the behaviour of Toxocara canis larvae in mice. Journal of Parasitology 46, 583-588.
59. Lightowlers, M.W., Colebrook, A.L., Gauci, C.G., Gauci, S.M., Kyngdon, C.T., Monkhouse, J.L., Vallejo-Rodriquez, C., Read, A.J, Rolfe, R.A. and Sato, C. (2003a) Vaccination against cestode parasites: anti-helmintic vaccines that work and why. Veterinary Parasitology 115, 83-123.
60. Lightowlers, M.W., Gauci, C.G., Chow, C., Drew, D.R., Gauci, S.M., Heath, D.D., Jackson, D.C., Dadley-Moore, D.L. and Read, A.J. (2003b) Molecular and genetic characterisation of the host-protective oncosphere antigens of taeniid cestode parasites. International Journal for Parasitology 33, 1207-1217.
61. Lloyd, S. (1993) Toxocara canis: the dog. In: Lewis, J.W. and Maizels, R.M. (eds) Toxocara and Toxocariasis: Clinical, Epidemiological, and Molecular Perspectives. Institute of Biology, London, pp. 11-24.
62. Lombardi, S., Vegni-Talluri, M., Banchieri, L. and Esposito, F. (1990) The in vitro adherence of murine eosinophil, neutrophils and non-induced macrophages to infective larvae of Toxocara canis (Nematoda, Ascarididae). International Journal for Parasitology 20, 603-613.
63. Loukas, A., Bethony, J.M., Williamson, A.L., Goud, G.N., Mendez, S., Zhan, B., Hawdon, J.M., Bottazzi, M., Brindley, P.J. and Hotez, P.J. (2004) Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms. Journal of Infection Diseases 189, 1952-1961.
64. Magnaval, J.F., Fabre, R., Maurieres, J.P., de Larrard, B. and de Larrard, C. (1991) Application of the Western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitology Research 77, 697-702.
65. Maizels, R.M., Gems, D.H. and Page, A.P. (1993) Synthesis and secretion of TES antigens from Toxocara canis infective larvae. In: Lewis, J.W. and Maizels, R.M. (eds) Toxocara and Toxocariasis: Clinical, Epidemiological, and Molecular Perspectives. Institute of Biology, London, pp. 141-150.
66. Maizels, R.M., Tetteh, K.K.A. and Loukas, A. (2000) Toxocara canis: genes expressed by the arrested infective larval stage of a parasitic nematode. International Journal for Parasitology 30, 495-508.
67. Meeusen, E.N. (1996) Rational design of nematode vaccines, natural antigens. International Journal for Parasitology 26, 813-818.
68. Meeusen, E.N. and Balic, A. (2000) Do eosinophils have a role in the killing of helminth parasites? Parasitology Today 16, 95-101.
69. Meeusen, E.N. and Piedrafita, D. (2003) Exploiting natural immunity to helminth parasites for the development of veterinary vaccines. International Journal for Parasitology 33, 1285-1290.
70. Mitchell, G.F. (1991) Co-evolution of parasites and adaptive immune responses. Parasitology Today 7, 2-5.
71. Morales, O.L., Lopez, M.C., Nicholls, R.S. and Agudelo, C. (2002) Identification of Tococara canis antigens by Western blot in experimentally infected rabbits. Revista do Instituto de Medicina Tropical de Sao Paulo 44, 213-216.
72. Munn, E.A. (1997) Rational design of nematode vaccines: hidden antigens. International Journal for Parasitology 27, 359-366.
73. New, R.R.C. (1994) Influence of liposome characteristics on their properties and fate. In: Philipott, J.R. and Schubert, R. (eds) Liposomes as Tools in Basic Research and Industry. CRC Press, Boca Raton, Florida, pp. 3-20.
74. Nicholas, W.L., Stewart, A.C. and Mitchell, G.F. (1984) Antibody responses to Toxocara canis using sera from parasite-infected mice and protection from toxocariasis by immunisation with ES antigens. Australian Journal of Experimental Biology and Science 62, 619-626.
75. Obwaller, A., Jensen-Jarolim, E., Auer, H., Huber, A., Kraft, D. and Aspók, H. (1998) Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexes. Parasite Immunology 20, 311-317.
76. Osborn, P.J., Heath, D.D. and Parmeter, S.N. (1981) Immunisation of lambs against infection with Taenia ovis using an extract of Taenia ovis eggs. Research in Veterinary Science 31, 90-92.
77. Parsons, J.C. and Grieve, R.B. (1990) Kinetics of liver trapping of infective larvae in murine toxocariasis. Journal of Parasitology 76, 529-536.
78. Parsons, J.C., Bowman, D.D. and Grieve, R.B. (1986) Tissue localization of excretory-secretory antigens of larval Toxocara canis in acute and chronic murine toxocariasis. American Journal of Tropical Medicine and Hygiene 35, 974-981.
79. Pawlowski, Z. (2001) Toxocariasis in humans: clinical expression and treatment dilemma. Journal of Helminthology 75, 1-8.
80. Premier, R.R., Jacobs, H.J., Brandon, M.R. and Meeusen, E.N.T. (1996) Distribution of antigen specific memory T cells in lymph nodes after immunization at peripheral or mucosal sites. Immunology and Cellular Biology 74, 265-273.
81. Robertson, B.D., Bianco, A.T., McKerrow, J.H. and Maizels, R.M. (1989) Toxocara canis: proteolytic enzymes secreted by the infective larvae in vitro. Experimental Parasitology 69, 30-36.
82. Rubel, D., Zunino, G., Santillan, G. and Wisnivesky, C. (2003) Epidemiology of Toxocara canis in the dog population from two areas of different socio-economic status, Greater Buenos Aires, Argentina. Veterinary Parasitology 115, 275-286.
83. Schantz, P.M. (1989) Toxocara larva migrans now. American Journal of Tropical Medicine and Hygiene 41, 21-34.
84. Schumunis, G.A. and Pacheco, G. (1976) Resistance to mice to superinfection with Toxocara canis. Journal for Parasitology 56, 306-307.
85. Sherwood, E.R., Williams, D.L. and Di Luzio, N.R. (1986) Glucan stimulates production of antitumour cytolytic/cytostatic factor(s) by macrophages. Journal of Biological Response Modifiers 5, 504-526.
86. Singh, M. and O'Hagan, D.T. (2003) Recent advances in veterinary vaccine adjuvants. International Journal for Parasitology 33, 469-478.
87. Smith, H.V., Quinn, R., Kusel, J.R. and Girdwood, R.W.A. (1981) The effect of temperature and antimetabolites on antibody binding to the outer surface of second stage Toxocara canis larvae. Molecular and Biochemical Parasitology 4, 183-193.
88. Šolty, J., Borošková, Z., Dubinsky P., Tomašovicová, O., Auer, H. and Aspock, H. (1996) Effect of glucan immunomodulator on the immune response and larval burdens in mice with experimental toxocariasis. Applied Parasitology 37, 161-167.
89. Sprent, J.F.A. (1952) On migratory behaviour of larvae of various Ascaris species in white mice. Journal of Infection Diseases 90, 165-176.
90. Sprent, J.F.A. (1958) Observations on the development of Toxocara canis (Werner, 1782) in the dog. Parasitology 48, 184-209.
91. Street, N.E. and Mosmann, T.R. (1991) Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB Journal 5, 171-177.
92. Sturchler, D., Schubarth, P., Gualzata, M., Gottstein, B. and Oettli, A. (1989). Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Annals of Tropical Medicine and Parasitology 83, 473-476.
93. Sugane, K. and Oshima, T. (1984) Induction of peripheral eosinophilia in mice by excretory and secretory antigen of Toxocara canis larvae. Journal of Helminthology 58, 143-147.
94. Sugane, K., Kusama, Y., Takamoto, M., Tominaga, A. and Takatsu, K. (1996) Eosinophilia, IL-5 level and recovery of larvae in IL-5 transgenic mice infected with Toxocara canis. Journal of Helminthology 70, 153-158.
95. Takamoto, M., Wang, Z.X., Watanabe, A. and Sugane, K. (2001) The measurement of parasite antigenspecific IgE levels using anti-IgE monoclonal antibodies and biotinylated antigens. Parasitology Research 87, 919-923.
96. Tsuji, N., Miyoshi, T., Islam, M.K., Isobe, T., Yoshihara, S., Arakawa, T., Matsumoto, Y. and Yokomizo, Y. (2004) Recombinant Ascaris 16-kilodalton protein-induced protection against Ascaris suum larval migration after intranasal vaccination in pigs. Journal of Infection Diseases 190, 1812-1820.
97. Uhlikova, M., Hubner, J., Kolarova, L. and Polackova, M. (1996) Immunological studies on human larval toxocarosis. Central European Journal of Public Health 4, 242-245.
98. Velebny S., Tomašovicová, O., Hrcková, G. and Dubinsky P. (1996) Effect of combined therapy with anthelmintics and an immunomodulator on the elimination of the migrating Toxocara canis larvae in the paratenic host. Helminthologia 33, 181-186.
99. Velebny S., Tomašovicová, O., Hrcková, G. and Dubinsky P. (1997) Toxocara canis in mice: are liposomes and immunomodulator able to enhance the larvicidal effect of the anthelmintic? Helminthologia 34, 147-153.
100. Velebny S., Hrcková, G., Tomašovicová, O. and Dubinsky P. (2000a) Treatment of larval toxocarosis in mice with fenbendazole entrapped in neutral and negatively charged liposomes. Helminthologia 37, 119-125.
101. Velebny S., Hrcková, G. and Tomašovicová, O. (2000b) Toxocara canis in mice: effect of stabilised liposomes on the larvicidal efficacy of fenbendazole and albendazole. Helminthologia 37, 195-198.
102. Vervelde, L., Bakker, N., Kooyman, F.N., Cornelissen, A.W., Bank, C.M., Nyame, A.K., Cummings, R.D.
103. and van Die, I. (2003) Vaccination-induced protection of lambs against the parasitic nematode Haemonchus contortus correlates with high IgG antibody responses to the LDNF glycan antigen. Glycobiology 13, 795-804.
104. WHO (1995) WHO Model Prescribing Information Drugs used Parasitic Diseases. WHO, Geneva.
105. Woodle, M.C. and Lasic, D.D. (1992) Sterically stabilized liposomes. Biochimica et Biophysica Acta 1113, 171-199.
106. Yip, H.C., Karulin, A.Y., Tary-Lehmann, M., Hesse, M.D., Radeke, H., Heeger, P.S., Trezza, R.P., Heinzel, F.P., Forsthuber, T. and Lehmann, P.V. (1999) Adjuvant-guided type-1 and type-2 immunity: infectious/ noninfectious dichotomy defines the class of response. Journal of Immunology 162, 3942-3949.